2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...
3h
How new advances in 3D bioprinting, organoids and organs on-a-chip aid in the fight against cancer
Scientists are exploring leading-edge technologies that could transform how cancer is studied, detected and treated by catching it earlier, when it's more treatable and survival rates are highest.
iShares Biotechnology ETF (IBB) offers targeted exposure to the U.S. biotechnology sector, providing investors with access to ...
UD chemical engineer wins the AIChE Langer Prize for efforts to harness biology to manage plastic waste sustainably ...
Ecosystem and Position GeoVax for Late-Stage Development and Market Readiness ATLANTA, GA - (NEWMEDIAWIRE) - GeoVax Labs, Inc ...
Learn how labman is advancing biologics manufacturing through AI-powered bioreactor technology, driving innovation in drug ...
Barresi, who is professor of biological sciences and chair of the Smith College neuroscience program, is creating artworks ...
Zomato's Deepinder Goyal has committed $25 million to longevity research, as entrepreneurs and investors start tapping into the growing Bryan Johnson-inspired quest for extending human lifespan in the ...
New Data Highlight Continued Potential of Radspherin to Prevent Disease Progression OSLO, Norway, Oct. 8, 2025 /PRNewswire/ -- Oncoinvent ASA, a clinical-stage ...
Existing oncology therapeutics are either so specific they can target only part of a tumor, or so generalized they kill healthy tissue.
Virtual screening methods fall broadly into two categories: ligand- and structure-based. Ligand-based virtual screening doesn’t require a target protein structure, Instead, it leverages known active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback